Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension Study of Perampanel in Painful Diabetic Neuropathy or Post-Herpetic Neuralgia
2007-005495-13Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2008
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perampanel in diabetic neuropathy and postherpetic neuralgia (PHN), sponsored by Eisai Co., Ltd. Primary endpoint: Primary Safety Endpoint(s). Started Jan 2008; status: completed.
02
Drugs
perampanel
03
Conditions
diabetic neuropathypostherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2007-005495-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005495-13.